CIK: 0001582384 · Show all filings
Period: Q2 2017 (← Previous) (Next →)
Filing Date: Aug 14, 2017
Total Value ($000): $376,136 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | KITE PHARMA INC | 2,410,034 | $249,848 | 66.4% | $58.66 | — | COM | 49803L109 |
| CSGP | COSTAR GROUP INC | 181,672 | $47,889 | 12.7% | $16.16 | +50.5% | COM | 22160N109 |
| — | NANTKWEST INC | 3,391,539 | $25,742 | 6.8% | $11.46 | — | COM | 63016Q102 |
| LPLA | LPL FINL HLDGS INC | 208,401 | $8,801 | 2.3% | $43.12 | -5.9% | COM | 50212V100 |
| EMB | ISHARES TR | 70,000 | $7,943 | 2.1% | $112.83 | — | JP MOR EM MK ETF | 464288281 |
| — | UNITI GROUP INC | 263,000 | $6,612 | 1.8% | $25.58 | — | COM | 91325V108 |
| — | MIMEDX GROUP INC | 391,000 | $5,853 | 1.6% | — | — | Call | 602496901 |
| SRNE | SORRENTO THERAPEUTICS INC | 2,799,790 | $5,599 | 1.5% | $12.08 | -83.8% | COM NEW | 83587F202 |
| — | PLAYA HOTELS & RESORTS NV | 300,000 | $3,585 | 1.0% | $11.95 | — | SHS | N70544106 |
| SBR | SABINE ROYALTY TR | 74,505 | $2,859 | 0.8% | $38.37 | — | UNIT BEN INT | 785688102 |
| BABA | ALIBABA GROUP HLDG LTD | 20,068 | $2,828 | 0.8% | $140.92 | — | SPONSORED ADS | 01609W102 |
| — | CURRENCYSHS JAPANESE YEN TR | 31,245 | $2,672 | 0.7% | $86.51 | — | JAPANESE YEN | 23130A102 |
| URGN | UROGEN PHARMA LTD | 135,000 | $2,439 | 0.6% | $17.36 | 0.0% | COM | M96088105 |
| — | NANTHEALTH INC | 238,828 | $1,010 | 0.3% | $12.47 | — | COM | 630104107 |
| — | CURRENCYSHARES EURO TR | 9,023 | $997 | 0.3% | — | — | Put | 23130C958 |
| — | POWERSHS DB MULTI SECT COMM | 29,400 | $728 | 0.2% | — | — | Call | 73936D907 |
| EDIT | EDITAS MEDICINE INC | 41,324 | $693 | 0.2% | $26.29 | -31.4% | COM | 28106W103 |
| — | ADVERUM BIOTECHNOLOGIES INC | 15,000 | $38 | 0.0% | $2.93 | — | COM | 00773U108 |